PK11195 + T1 lesions* | ||||||||||
Patient no. | Age (y) | Sex | Disease duration (y) | Expanded disability status scale | GM volume (cm3) | WM volume (cm3) | T2 lesion load (cm3) | T1 lesions (n) | n | % |
1 | 51 | F | 9 | 6.0 | 742.0 | 721.4 | 22 | 3 | 3 | 100 |
2 | 39 | F | 15 | 8.0 | 782.1 | 698.6 | 102 | 19 | 11 | 58 |
3 | 61 | M | 16 | 6.5 | 775.2 | 756.5 | 50 | 19 | 13 | 68 |
4 | 51 | M | 21 | 3.5 | 713.8 | 721.3 | 41 | 22 | 11 | 50 |
5 | 48 | F | 23 | 7.5 | 710.7 | 759.4 | 22 | 1 | 0 | 0 |
6 | 33 | F | 9 | 6.5 | 782.7 | 731.3 | 20 | 11 | 6 | 55 |
7 | 60 | F | 15 | 7.5 | 769.9 | 715.5 | 33 | 8 | 5 | 63 |
8 | 48 | F | 6 | 7.5 | 794.0 | 655.0 | 132 | 33 | 20 | 61 |
9 | 66 | F | 12 | 6.0 | 609.2 | 694.2 | 58 | 17 | 9 | 53 |
10 | 40 | M | 7 | 4.0 | 623.2 | 672.7 | 128 | 31 | 22 | 71 |
↵* No. of chronic T1 lesions with 11C-PK11195 uptake and percentage of 11C-PK11195–positive lesions of all T1 hypointense lesions.